Summary
Venus Medtech HangZhou Inc (Venus MedTech) is a medical device company that focus on development and commercialization of transcatheter heart valve products for structural heart diseases. The company's product portfolio includes venusA- valve, venusP- valve, V8/TAV8, and TriGUARD3 CEP device. It's products find applications in transcatheter aortic valve replacement system, anti-embolic distal brain protection device, TAV8 balloon dilatation catheter, transcatheter prosthetic pulmonary valve system, TMVr&TTVr mitral and tricuspid valve repair and replacement, RDN therapy, hypertrophic cardiomyopathy, transcatheter pulmonary valve replacement, transcatheter mitral valve replacement and transcatheter tricuspid valve replacement mainly associated with aortic stenosis and pulmonic, mitral and tricuspid regurgitation. Venus MedTech is headquartered in Binjiang, Hangzhou, China.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook